Reference List

Ahrens, E.H. et al. (1961) ‘Carbohydrate-induced and fat-induced lipemia’, Transactions of the Association of American Physicians, 74, pp. 134–146.

Berry, K. D. (2019) 'Lies My Doctor Told Me' Second Edition (p. 141). Victory Belt Publishing.

Brand, M.D. (2000) ‘Uncoupling to survive? The role of mitochondrial inefficiency in ageing’, Experimental Gerontology, 35(6–7), pp. 811–820.

Brebach, K. (2018) Dementia by Prescription?, Medium. Available at: (Accessed: 25 March 2022).

Budoff, M.J. (2012) ‘Screening for Ischemic Heart Disease with Cardiac CT: Current Recommendations’, Scientifica, 2012, p. 812046. doi:10.6064/2012/812046.

Budoff, M.J. and Shinbane, J.S. (2016) Cardiac CT Imaging: Diagnosis of Cardiovascular Disease. Springer.

Byrne, P. et al. (2022) ‘Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis’, JAMA Internal Medicine [Preprint]. doi:10.1001/jamainternmed.2022.0134.

Cederberg, H. et al. (2015) ‘Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort’, Diabetologia, 58(5), pp. 1109–1117. doi:10.1007/s00125-015-3528-5.

Chudzik, A. et al. (2021) ‘Probiotics, Prebiotics and Postbiotics on Mitigation of Depression Symptoms: Modulation of the Brain–Gut–Microbiome Axis’, Biomolecules, 11(7), p. 1000. doi:10.3390/biom11071000.

CVD Statistics (2022). Available at: (Accessed: 28 April 2022).

Dehghan, M. et al. (2017) ‘Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study’, Lancet (London, England), 390(10107), pp. 2050–2062. doi:10.1016/S0140-6736(17)32252-3.

Diamond, D.M. and Ravnskov, U. (2015) ‘How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease’, Expert Review of Clinical Pharmacology, 8(2), pp. 201–210. doi:10.1586/17512433.2015.1012494.

Epigenix Foundation (2017) David Diamond, Ph.D.: Assessing the Myth that Elevated Cholesterol Causes Cardiovascular Disease. Available at: (Accessed: 18 April 2022).

Feinman, R.D. et al. (2015) ‘Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base’, Nutrition, 31(1), pp. 1–13. doi:10.1016/j.nut.2014.06.011.

Feinman, R.D. and Volek, J.S. (2006) ‘Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss’, Nutrition & Metabolism, 3, p. 24. doi:10.1186/1743-7075-3-24.

Ferrières, J. (2004) ‘The French paradox: lessons for other countries’, Heart, 90(1), pp. 107–111. Available at: (Accessed: 26 April 2022).

Fettke, B. (2019) Nutrition Science: How did we get here?, Youtube. Available at:

Flegal, K.M. et al. (2012) ‘Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010’, JAMA - Journal of the American Medical Association, 307(5). doi:10.1001/jama.2012.39.

Framingham Risk Score - an overview | ScienceDirect Topics (no date). Available at: (Accessed: 1 April 2022).

Geleijnse, J.M. et al. (2004) ‘Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study’, The Journal of Nutrition, 134(11), pp. 3100–3105. doi:10.1093/jn/134.11.3100.

Gigerenzer, G., Wegwarth, O. and Feufel, M. (2010) ‘Misleading communication of risk’, BMJ, 341, p. c4830. doi:10.1136/bmj.c4830.

Hess, J. (1978) ‘Harvard’s Sugar-Pushing Nutritionist’, The Saturday Review, August, pp. 10–14. Available at: (Accessed: 21 June 2022).

Hoenselaar, R. (2012) ‘Further response from Hoenselaar’, British Journal of Nutrition, 108(5), pp. 939–942.

Ioannidis, J.P.A. et al. (2017) ‘How to survive the medical misinformation mess’, European Journal of Clinical Investigation, 47(11). doi:10.1111/eci.12834.

Kearns, C.E., Schmidt, L.A. and Glantz, S.A. (2016) ‘Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents’, JAMA Internal Medicine, 176(11), pp. 1680–1685. doi:10.1001/jamainternmed.2016.5394.

Keys’ Scientific Abandon (no date). Available at: (Accessed: 28 April 2022).

Khalil, Z. et al. (2021) ‘The medical benefits of vitamin k2 on calcium-related disorders’, Nutrients, 13(2). doi:10.3390/nu13020691.

Kristensen, M.L., Christensen, P.M. and Hallas, J. (2015) ‘The effect of statins on average survival in randomised trials, an analysis of end point postponement’, BMJ Open, 5(9), p. e007118. doi:10.1136/bmjopen-2014-007118.

La Berge, A.F. (2008) ‘How the Ideology of Low Fat Conquered America’, Journal of the History of Medicine and Allied Sciences, 63(2), pp. 139–177.

Li, Y. et al. (2018) ‘Effect of vitamin K2 on type 2 diabetes mellitus: A review’, Diabetes Research and Clinical Practice, 136. doi:10.1016/j.diabres.2017.11.020.

Mandatori, D. et al. (2021) ‘The dual role of vitamin K2 in “bone-vascular crosstalk”: Opposite effects on bone loss and vascular calcification’, Nutrients, 13(4). doi:10.3390/nu13041222.

McDougall, J.A. et al. (2013) ‘Long-Term Statin Use and Risk of Ductal and Lobular Breast Cancer among Women 55 to 74 Years of Age’, Cancer Epidemiology, Biomarkers & Prevention, 22(9), pp. 1529–1537. doi:10.1158/1055-9965.EPI-13-0414.

de la Monte, S.M. and Wands, J.R. (2008) ‘Alzheimer’s Disease Is Type 3 Diabetes–Evidence Reviewed’, Journal of diabetes science and technology (Online), 2(6), pp. 1101–1113. Available at: (Accessed: 28 April 2022).

Moro, T. et al. (2020) ‘Time-restricted eating effects on performance, immune function, and body composition in elite cyclists: a randomized controlled trial’, Journal of the International Society of Sports Nutrition, 17(1), p. 65. doi:10.1186/s12970-020-00396-z.

‘MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial’ (2002) The Lancet, 360(9326), pp. 7–22. doi:10.1016/S0140-6736(02)09327-3.

New analysis shows statins have ‘minimal’ benefits (no date) Investigative journalism. Available at: (Accessed: 25 April 2022).

Norwitz, N.G. et al. (2022) ‘Elevated LDL Cholesterol with a Carbohydrate-Restricted Diet: Evidence for a “Lean Mass Hyper-Responder” Phenotype’, Current Developments in Nutrition, 6(1), p. nzab144. doi:10.1093/cdn/nzab144.

Number Needed to Treat (NNT): A tool to analyze harms and benefits (no date) Available at: (Accessed: 18 April 2022).

Östergren, J. et al. (2008) ‘The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes’, Journal of Hypertension, 26(11), pp. 2103–2111. doi:10.1097/HJH.0b013e328310e0d9.

Padala, K.P. et al. (2012) ‘The Effect of HMG-CoA Reductase Inhibitors on Cognition in Patients With Alzheimer’s Dementia: A Prospective Withdrawal and Rechallenge Pilot Study’, The American Journal of Geriatric Pharmacotherapy, 10(5), pp. 296–302. doi:10.1016/j.amjopharm.2012.08.002.

Paoli, A. et al. (2014) ‘Ketogenic diet in neuromuscular and neurodegenerative diseases’, BioMed Research International, 2014. doi:10.1155/2014/474296.

Pollack, H. (1957) ‘Editorial: Dietary Fats and Their Relationship to Atherosclerosis’, Circulation, 16(2), pp. 161–162.

Popescu, A. and German, M. (2021) ‘Vitamin K2 holds promise for Alzheimer’s prevention and treatment’, Nutrients, 13(7). doi:10.3390/nu13072206.

Ravnskov, U. et al. (2012) ‘No scientific support for linking dietary saturated fat to CHD’, British Journal of Nutrition, 107(3), pp. 455–457. doi:10.1017/S000711451100660X.

Ravnskov, U. et al. (2016) ‘Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review’, BMJ Open, 6(6), p. e010401. doi:10.1136/bmjopen-2015-010401.

Ray, K.K. et al. (2010) ‘Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants’, Archives of Internal Medicine, 170(12), pp. 1024–1031. doi:10.1001/archinternmed.2010.182.

Review Explores Therapeutic Potential of Ketone Therapy For CV Disease (no date) American College of Cardiology. Available at: (Accessed: 1 April 2022).

Ridker, P.M. et al. (2008) ‘Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein’, New England Journal of Medicine, 359(21), pp. 2195–2207. doi:10.1056/NEJMoa0807646.

Rifkind, B.M. (1984) ‘Lipid research clinics coronary primary prevention trial: Results and implications’, The American Journal of Cardiology, 54(5), pp. 30–34. doi:10.1016/0002-9149(84)90854-3.

Röggla, G., Fasan, M. and Kapiotis, S. (2007) ‘Treating hypertriglyceridemia’, CMAJ, 177(6), pp. 603–603. doi:10.1503/cmaj.1070055.

Rong, Y. et al. (2013) ‘Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies’, BMJ, 346(jan07 2), pp. e8539–e8539. doi:10.1136/bmj.e8539.

Sechtem, U. et al. (no date) ‘2013 ESC guidelines on the management of stable coronary artery disease—addenda’, p. 32.

Sever, P.S. et al. (2003) ‘Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial’, The Lancet, 361(9364), pp. 1149–1158. doi:10.1016/S0140-6736(03)12948-0.

Sever, P.S. et al. (2008) ‘The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure’, European Heart Journal, 29(4), pp. 499–508. doi:10.1093/eurheartj/ehm583.

Skeaff, C.M. and Miller, J. (2009) ‘Dietary Fat and Coronary Heart Disease: Summary of Evidence from Prospective Cohort and Randomised Controlled Trials’, Annals of Nutrition & Metabolism, 55(1/3), pp. 173–201. Available at: (Accessed: 18 April 2022).

Stamler, J., Wentworth, D. and Neaton, J.D. (1986) ‘Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?: Findings in 356 222 Primary Screenees of the Multiple Risk Factor Intervention Trial (MRFIT)’, JAMA, 256(20), pp. 2823–2828. doi:10.1001/jama.1986.03380200061022.

Time (1961) ‘Medicine: The Fat of the Land’, 13 January. Available at:,33009,828721-1,00.html (Accessed: 25 April 2022).

Tom Bilyeu (2022) What You Know About the KETO DIET Is WRONG! This Is What NEW STUDIES Are Showing | Dr. Steven Gundry. Available at: (Accessed: 28 March 2022).

Wen, L. et al. (2018) ‘Vitamin K‑dependent proteins involved in bone and cardiovascular health (Review)’, Molecular Medicine Reports, 18(1), pp. 3–15. doi:10.3892/mmr.2018.8940.

Why People in ‘Blue Zones’ Live Longer Than the Rest of the World (2017) Healthline. Available at: (Accessed: 28 March 2022).

Yourman, L.C. et al. (2021) ‘Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis’, JAMA Internal Medicine, 181(2), pp. 179–185. doi:10.1001/jamainternmed.2020.6084.

Yudkin, J. (1957) ‘Diet and coronary thrombosis. Hypothesis and fact.’, Lancet, 273, pp. 155–162. Available at: (Accessed: 18 April 2022).

Yurista, S.R. et al. (2021) ‘Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease’, Journal of the American College of Cardiology, 77(13), pp. 1660–1669. doi:10.1016/j.jacc.2020.12.065.